Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Return on Equity (ROE)
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | (64.4%) | (61.9%) | (31.2%) | (18.8%) | (16.6%) | (22.6%) | (43.8%) | 86.7% | 26.5% | 15.5% | 20.5% | 22.1% | 22.6% | 32.8% | 21.3% | 31.8% | 54.2% | 20.9% | 16.3% | 16.0% |
Regeneron Pharmaceuticals, Inc. (REGN) Return on Equity (ROE) comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Return on Equity (ROE)?
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 13.7%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Regeneron Pharmaceuticals, Inc. have been 25.1% over the past three years, and 27.2% over the past five years.
2) Is Regeneron Pharmaceuticals, Inc.'s Return on Equity (ROE) Good?
As of today, Regeneron Pharmaceuticals, Inc.'s Return on Equity (ROE) is 13.7%, which is higher than industry median of (52.8%). It indicates that Regeneron Pharmaceuticals, Inc.'s Return on Equity (ROE) is Good.